hydromorphone hydrochloride
NDC 0574-0297, hydromorphone hydrochloride, tablet, extended release, from Padagis US LLC.
- Product NDC
- 0574-0297
- Status
- Listed
- Labeler
- Padagis US LLC
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204278
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/0574-0297 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HYDROMORPHONE HYDROCHLORIDE32 mg/1
Pharmacologic classes
Full Opioid Agonists [MoA]; Opioid Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0574-0297-01 | 00574029701 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0574-0297-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/780a2616-0392-4715-bc50-71799bea1957
Use it
Look up 0574-0297 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0574-0297 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0574-0297. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.